Cannabinoids in Focus after GW Pharmaceuticals Snapped up for €6B
This month’s €6B acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been…
February 18, 2021 - 6 minutes
GW Pharmaceuticals
UK Loosens Controls on GW’s Cannabinoid Epilepsy Drug
A cannabinoid medication marketed by GW Pharmaceuticals for the treatment of severe forms of epilepsy…
June 26, 2020 - 4 minutes
Cannabinoid Drugs Company Raises $300M in Public Offering
GW Pharmaceuticals, a British biotech developing cannabinoid drugs, is on a high after a successful…
October 8, 2018 - 2 minutes
Update: The FDA Approves First Cannabinoid Treatment for Epilepsy
Update (26/06/2018): The FDA has approved GW Pharmaceutical's drug Epidiolex in two severe forms of epilepsy.…
June 26, 2018 - 2 minutes
GW Pharma’s Latest Cannabinoid Drug Pegged Back by a Placebo in Phase II
One of GW Pharma's cannabinoid drugs for epilepsy has suffered a set back in a…
February 22, 2018 - 2 minutes
Yet More Good News for GW Pharma’s Cannabinoid Drug Against Epilepsy
New data in The Lancet provides further support for GW Pharma's drug, Epidiolex, for the…
January 25, 2018 - 3 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
January 9, 2018 - 5 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
December 18, 2017 - 9 minutes
Signed, Sealed. Will GW Pharma’s Epilepsy Treatment Be a 2018 Blockbuster?
GW Pharma might be about to join the likes of Genmab in the biotech blockbuster…
December 15, 2017 - 2 minutes
UK Cannabinoid Company Loses 9% and a Competitor after American Phase II Failure
Zynerba Pharmaceuticals cannabinoid drug for epilepsy missed all of its endpoints costing the company's stock…
August 9, 2017 - 2 minutes
More “FDA Love” for Cannabis Company with Orphan Drug Designation
Last year was a doozy for biotech, but it was spectacular for GW Pharmaceuticals. Its…
March 29, 2017 - 2 minutes
Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials
GW Pharmaceuticals announced Phase II results for a cannabinoid drug combination with the potential to…
February 7, 2017 - 2 minutes
